Science Current Events | Science News | Brightsurf.com
 
corner top left block corner top right

Risk factors for CCSVI are similar to risk factors for developing MS, UB study shows

December 01, 2011

BUFFALO, N.Y. - The first study to investigate risk factors for the vascular condition called CCSVI (chronic cerebrospinal venous insufficiency) in volunteers without neurological disease has identified what the researchers call a remarkable similarity between this condition and possible or confirmed risk factors for multiple sclerosis (MS).

The University at Buffalo study investigated associations between CCSVI and demographic, clinical and environmental risk factors in a large control group of volunteers who did not have known central nervous system disease.

"Our results suggest that risk factors for CCSVI in this group of volunteers are remarkably similar to those of possible or confirmed importance to MS, but we do not yet understand the whole story," says Robert Zivadinov, MD, PhD, FAAN, professor of neurology at the UB School of Medicine and Biomedical Sciences, and senior author on the study.

He discusses the study's results in the video at http://www.youtube.com/watch?v=Vip7QAtlfqE.

Published today (Nov. 30) in PLoS One, the current study of 252 volunteers "was designed to help provide scientists and the MS patient community with new information that, combined with the results of studies that are still ongoing at UB, will ultimately help explain CCSVI and its relationship to MS," according to Kresimir Dolic, a lead author on the study. Dolic, a radiologist from the Department of Radiology, University Hospital, Split, Croatia, was a visiting fellow at the Buffalo Neuroimaging Analysis Center, part of UB's Department of Neurology, where the study was conducted.

CCSVI refers to impaired blood flow from the central nervous system to the periphery. It has been hypothesized that this narrowing of veins restricts blood flow from the brain, altering brain drainage, and may contribute to brain tissue injury that is associated with MS.

Yet, while CCSVI has generated intense interest among MS patients worldwide, and while independent scientific studies, including one of the largest to date being conducted by Zivadinov and UB colleagues, have suggested an association with MS, none have found conclusively that the condition is associated with MS.

For this reason, the UB team decided that it was critical to proceed with this prospective study to determine the risk factors for CCSVI in individuals without neurological disease.

The study found that CCSVI risk factors occurred more frequently in 1) those with a history of mononucleosis, i.e. infected with Epstein-Barr virus; 2) those with irritable bowel syndrome; 3) those who smoke or have a history of smoking.

"All three are confirmed risk factors for MS," said Bianca Weinstock-Guttman, MD, second author on the study and professor of neurology at UB. According to the results, individuals with CCSVI were 2.7 times more likely than individuals without CCSVI to have infectious mononucleosis, 3.9 times more likely to have irritable bowel syndrome and 1.98 times more likely to have a history of smoking.

"Our finding that a risk factor that is highly significant for MS - Epstein-Barr virus, indicated by a history of infectious mononucleosis - is strongly associated with CCSVI, is important," says Zivadinov.

"This is the first time a connection has been found between Epstein-Barr virus and CCSVI.

"We know that Epstein-Barr virus is associated with an increased risk for MS," he explains. "We also know that having mononucleosis when you are young increases the MS risk several-fold. So our finding that Epstein-Barr virus is also correlated with CCSVI is a novel finding that must be explored in future studies."

In addition, individuals with heart disease -- which is not a known MS risk factor -- were 2.7 times more likely to have CCSVI, and those with heart murmurs, in particular, were 4.9 times more likely to have CCSVI. Zivadinov added that the study's finding of a weak, protective effect from the use of dietary supplements was also noted and has to be further explored.

The UB team cautions that the study was preliminary and that these findings must be expanded upon and confirmed in further studies. The volunteer subjects were all part of the prospective Combined Transcranial and Extracranial Venous Doppler Evaluation study at UB. They were either independent individuals, or spouses or relatives of MS patients.

The controls were purposely selected from different sources of recruitment, Zivadinov explains.

"Spouses had no genetic similarity but may have shared environmental risk factors with MS patients, while relatives of MS patients had shared both genetic and environmental background," he says. "However, no differences in risk factors or frequency of CCSVI were found according to the various sources of recruitment."

All volunteers were screened for medical histories and underwent physical exams and Doppler sonography examinations of the neck; they also responded to an extensive environmental questionnaire. Individuals were considered to have CCSVI if they had at least two positive venous hemodynamic criteria on Doppler sonography.

University at Buffalo




CCSVI as the Cause of Multiple Sclerosis: The Science Behind the Controversial Theory (McFarland Health Topics)

CCSVI as the Cause of Multiple Sclerosis: The Science Behind the Controversial Theory (McFarland Health Topics)
by Marie A. Rhodes (Author), Foreword by E. Mark Haacke (Author), Elaine A. Moore (Author), Elaine A. Moore (Editor)


Paolo Zamboni MD published his first paper describing the theory that MS may be a type of venous insufficiency in 2006.  Since that time,  he has published numerous other groundbreaking studies that have further elucidated the idea.  But Dr Zamboni isn't the first MS researcher to notice problems with veins in MS; the fact  that enlarged veins are in the center of MS lesions was noted as early as the 1860's and is well known today.  But what do these widened veins tell us about MS?This book follows this journey of discovery and highlights related MS research that supports the theory.  Referencing over 250 research papers published in the field of MS, it tells the MS story from a venous perspective.For interested patients it also includes a detailed section on how these...

The Driscoll Theory: Part 2

The Driscoll Theory: Part 2
by Warnick Publishing


From the Publisher:
In The Driscoll Theory: Part 2, Dr. Diana Driscoll (both doctor and patient) proposes a complete paradigm shift for the cause and treatment of dysautonomia in the Ehlers-Danlos Syndrome patient. As a patient and mother of children also affected by POTS (Postural Orthostatic Tachycardia Syndrome), she was dissatisfied with the current treatments and the lack of answers to the cause of autonomic dysfunction. As she likes to say, she “has donated her body to science while still using it” and began retrospective analyses and clinical trials, while working with various medications.

As a therapeutic optometrist (on professional disability), her research naturally began by looking to the eyes, and progressed to the involvement of hydrocephalus,...

  What you need to know: about CCSVI.(special report on CCSVI)(chronic cerebrospinal venous insufficiency)(Brief article): An article from: Momentum
by Unavailable (Author)


This digital document is an article from Momentum, published by National Multiple Sclerosis Society on June 22, 2010. The length of the article is 333 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: What you need to know: about CCSVI.(special report on CCSVI)(chronic cerebrospinal venous insufficiency)(Brief article)
Author: Unavailable
Publication: Momentum (Magazine/Journal)
Date: June 22, 2010
Publisher: National Multiple Sclerosis Society
Volume: 3 Issue: 3 Page: S1(1)

Article Type: Brief article

Distributed by Gale, a part of Cengage...

The Driscoll Theory: Discovering the Cause of POTS in Ehlers-Danlos Syndrome: The Role of External Communicating Hydrocephalus, Mast Cell Disease and ... Syndrome) in Ehlers-Danlos Syndrome

The Driscoll Theory: Discovering the Cause of POTS in Ehlers-Danlos Syndrome: The Role of External Communicating Hydrocephalus, Mast Cell Disease and ... Syndrome) in Ehlers-Danlos Syndrome
by Diana Driscoll O.D. (Author)




CCSVI as the Cause of Multiple Sclerosis byHaacke

CCSVI as the Cause of Multiple Sclerosis byHaacke
by Haacke (Author)




CCSVI as the Cause of Multiple Sclerosis byRhodes

CCSVI as the Cause of Multiple Sclerosis byRhodes
by Rhodes (Author)




Paperback:CCSVI as the Cause of Multiple Sclerosis byHaacke

Paperback:CCSVI as the Cause of Multiple Sclerosis byHaacke
by n/a and n/a (Author)




CCSVI as the Cause of Multiple Sclerosis: The Science Behind the Controversial Theory (McFarland Hea [Paperback]

CCSVI as the Cause of Multiple Sclerosis: The Science Behind the Controversial Theory (McFarland Hea [Paperback]
by Marie A. Rhodes (Author)




Managing Multiple Sclerosis Naturally: A Self-help Guide to Living with MS

Managing Multiple Sclerosis Naturally: A Self-help Guide to Living with MS
by Judy Graham (Author)


A totally revised and updated edition of the first book to offer a holistic approach to slowing the progression of MS

• Provides guidance on special diets and nutritional supplements, exercise, alternative therapies, and the effects of negative and positive thoughts on MS

• Explains how to reduce toxic overload from mercury and chemicals

• Includes life wisdom and coping strategies from others who suffer with MS

Judy Graham is an inspiration. Diagnosed with multiple sclerosis when she was just 26 years old, 35 years later Judy Graham is still walking, working, and has successfully birthed and raised a son who is now an adult. In this totally revised and updated edition of her groundbreaking Multiple Sclerosis, first published in...

Multiple Sclerosis Therapeutics

Multiple Sclerosis Therapeutics
by Jeffrey A. Cohen (Editor), Richard A. Rudick (Editor)


This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis treatment, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management. The status of the rapidly evolving field of disease-modifying drugs is presented, with emphasis on the most promising therapies currently being tested. Experts discuss disease and symptom management for MS subtypes, including neuromyelitis optica and pediatric MS. In addition, key scientific advances in MS pathology, genetics, immunology and epidemiology are presented. The fourth edition has been extensively revised, featuring more than 50% new material. All chapters have been substantially updated to provide current information on...

corner bottom left corner bottom right
© 2012 BrightSurf.com